H. Feng

Development and Validation of a Novel Immune-Related Prognostic Model and the Potential Mechanism in Metastatic Synovial Sarcoma

Xiaojun Zhu, Hongmin Chen, Ming Gong, 2021, SSRN Electronic Journal.

An integrated biomarker of PD‐L1 expression and intraepithelial CD8 + T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases

Dong Zhou, K. Yin, Xuchao Zhang, 2022, Thoracic cancer.

Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study

A. Addeo, G. Banna, I. Oh, 2022, Translational lung cancer research.

Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma‐like carcinoma

Yi-long Wu, Xue-Ning Yang, K. Yin, 2019, Thoracic cancer.

High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2021, Thoracic Cancer.

P1.01-28 Mutational Heterogeneity Between Primary Pulmonary Cancer Lesions and Matched Brain Metastases

Y. Wu, K. Yin, Z. Lv, 2019, Journal of Thoracic Oncology.